중등도 이상 허혈성 뇌졸중 환자의 뇌졸중 아형에 따른 요산과 조기 예후와의 관계
Association of Serum Uric Acid With Early Prognosis Stratified by the Stroke Subtype in Patients With Moderate to Severe Ischemic Stroke
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The role of uric acid in cerebrovascular disease is controversial. Uric acid may be an independent risk factor for cerebrovascular diseases but its neuroprotective role as an antioxidant has also been suggested. We studied the effects of uric acid on the early prognosis in acute ischemic stroke. Methods: The subjects were 721 patients with moderate-to-severe acute stroke who arrived at hospital within 48 hours from the onset of symptoms. Patients were divided into quartiles based on serum uric acid levels at admission. In-hospital stroke outcome were calculated on the National Institutes of Health Stroke Scale (NIHSS) and analyzed by multivariate logistic regression. Results: Differences in NIHSS scores between baseline and discharge in the patients were not significantly related to serum uric acid levels. However, in large artery atherosclerosis group, the proportion of patients with neurological improvement and differences in NIHSS score between baseline and discharge differed between the quartile uric acid groups (p<0.01 and p=0.04, respectively). A multivariate analysis adjusting for known vascular risk factors showed that a higher uric acid level was associated with a higher probability of a good in-hospital outcome (odds ratio, 1.31 per additional 1 mg/dL; 95% confidence interval, 1.07-1.60 per additional 1 mg/dL), but only in those with large-artery atherosclerosis. Conclusions: Uric acid level is independently correlated with the neurological improvement in patients with acute ischemic stroke caused by large-artery atherosclerosis.
Abstract
Background: The role of uric acid in cerebrovascular disease is controversial. Uric acid may be an independent risk factor for cerebrovascular diseases but its neuroprotective role as an antioxidant has also been suggested. We studied the effects of uric acid on the early prognosis in acute ischemic stroke. Methods: The subjects were 721 patients with moderate-to-severe acute stroke who arrived at hospital within 48 hours from the onset of symptoms. Patients were divided into quartiles based on serum uric acid levels at admission. In-hospital stroke outcome were calculated on the National Institutes of Health Stroke Scale (NIHSS) and analyzed by multivariate logistic regression. Results: Differences in NIHSS scores between baseline and discharge in the patients were not significantly related to serum uric acid levels. However, in large artery atherosclerosis group, the proportion of patients with neurological improvement and differences in NIHSS score between baseline and discharge differed between the quartile uric acid groups (p<0.01 and p=0.04, respectively). A multivariate analysis adjusting for known vascular risk factors showed that a higher uric acid level was associated with a higher probability of a good in-hospital outcome (odds ratio, 1.31 per additional 1 mg/dL; 95% confidence interval, 1.07-1.60 per additional 1 mg/dL), but only in those with large-artery atherosclerosis. Conclusions: Uric acid level is independently correlated with the neurological improvement in patients with acute ischemic stroke caused by large-artery atherosclerosis.
참고문헌 (38)
- Dimitroula HV, "The role of uric acid in stroke: the issue remains unresolved", Neurologist, 14, pp.238~242 (2008)
- Feig DI, "Uric acid and cardiovascular risk", N Engl J Med, 359, pp.1811~1821 (2008)
- Love S, "Oxidative stress in brain ischemia", Brain Pathol, 9, pp.119~131 (1999)
- Becker BF, "Towards the physiological function of uric acid", Free Radic Biol Med, 14, pp.615~631 (1993)
- Cherubini A, "Antioxidant profile and early outcome in stroke patients", Stroke, 31, pp.2295~2300 (2000)
- Leinonen JS, "Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke", Stroke, 31, pp.33~39 (2000)
- Romanos E, "Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke", J Cereb Blood Flow Metab, 27, pp.14~20 (2007)
- Brouns R, "Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome", Clin Chem Lab Med, 48, pp.383~390 (2010)
- Hong JM, "Influence of recanalization on uric acid patterns in acute ischemic stroke", CerebrovascDis, 29, pp.431~439 (2010)
- Amaro S, "A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke", Stroke, 38, pp.2173~2175 (2007)
- Netea MG, "The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice", Blood, 89, pp.577~582 (1997)
- Brand FN, "Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study", Am J Epidemiol, 121, pp.11~18 (1985)
- Freedman DS, "Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up study", Am J Epidemiol, 141, pp.637~644 (1995)
- Yoo TW, "Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome", Circ J, 69, pp.928~933 (2005)
- Schretlen DJ, "Serum uric acid and brain ischemia in normal elderly adults", Neurology, 69, pp.1418~1423 (2007)
- Adams HP Jr, "Baseline NIH stroke scale score strongly predicts outcome after stroke: A report of the Trial of org 10172 in Acute Stroke Treatment (TOAST)", Neurology, 53, pp.126~131 (1999)
- Chamorro A, "Yin and yang of uric acid in patients with stroke", Stroke, 35, pp.11~12 (2004)
- Dawson J, "The continued yin and yang of uric acid", Stroke, 39, pp.9~10 (2008)
- Droge W, "Free radicals in the physiological control of cell function", Physiol Rev, 82, pp.47~95 (2002)
- Ginsberg MH, "Release of platelet constituents by monosodium urate crystals", J Clin Invest, 60, pp.999~1007 (1977)
- Rao GN, "Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression", J Biol Chem, 266, pp.8604~8608 (1991)
- Amaro S, "Uric acid administration in patients with acute stroke: a novel approach to neuroprotection", Expert Rev Neurother, 8, pp.259~270 (2008)
- Mazzali M, "Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism", Am J Physiol Renal Physiol, 282, pp.991~997 (2002)
- Khosla UM, "Hyperuricemia induces endothelial dysfunction", Kidney Int, 67, pp.1739~1742 (2005)
- Bos MJ, "Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study", Stroke, 37, pp.1503~1507 (2006)
- Hozawa A, "Serum uric acid and risk of ischemic stroke: the ARIC Study", Atherosclerosis, 187, pp.401~407 (2006)
- Tomita M, "Does hyperuricemia affect mortality? A prospective cohort study of japanese male workers", J Epidemiol, 10, pp.403~409 (2000)
- Sakata K, "NIPPON DATA 80 Research Group. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged", Eur J Epidemiol, 17, pp.461~468 (2001)
- Lee JH, "A comparison study on therapeutic efficacy of urokinase vs. heparin in acute ischemic stroke", J Korean Neurol Assoc, 12, pp.225~236 (1994)
- Wong KY, "Urate predicts subsequent cardiac death in stroke survivors", Eur Heart J, 23, pp.788~793 (2002)
- Chamorro A, "Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke", Stroke, 33, pp.1048~1052 (2002)
- Karagiannis A, "Serum uric acid as an independent predictor of early death after acute stroke", Circ J, 71, pp.1120~1127 (2007)
- Phillis JW, "A radical view of cerebral ischemic injury", Prog Neurobiol, 42, pp.441~448 (1994)
- Zweier JL, "Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues", Proc Natl Acad Sci USA, 85, pp.4046~4050 (1988)
- Nam HS, "Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients", J Neurol Sci, 281, pp.69~73 (2009)
- Saver JL, "Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials", Stroke, 38, pp.3055~3062 (2007)
- Akdemir H, "The effect of allopurinol on focal cerebral ischaemia: an experimental study in rabbits", Neurosurg Rev, 24, pp.131~135 (2001)
- Muir SW, "Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, doubleblind, placebo-controlled trial", Stroke, 39, pp.3303~3307 (2008)